Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2020-03-24 Board/Management Inform…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of the company 'SR Biotech'. It details the outgoing CEO, the incoming CEO, the reason for the change (resignation and new appointment), and the date of the change. This falls directly under the category of board or management changes.
2020-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to specific executives and employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and employee compensation via stock options is classified as a regulatory filing related to share-based incentives, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2020-03-24 Korean
감사보고서제출
Report Publication Announcement Classification · 95% confidence The document is a short regulatory filing (1,201 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion and key financial figures as reported by the external auditor, rather than the full, lengthy audit report document itself. According to the 'Menu vs Meal' rule, this is an announcement of the report's submission, which falls under the Report Publication Announcement (RPA) category.
2020-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for SR Biotech. It outlines the date, location, and specific agenda items (financial statement approval, director/auditor appointments, and business purpose changes). This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of upcoming meeting details and request their participation/votes.
2020-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SR Biotech. It contains the agenda for the upcoming Annual General Meeting (AGM), including financial statement approval, director appointments, and proposed amendments to the articles of incorporation. In the context of financial filings, documents that provide the agenda, proxy information, and meeting details for an AGM are classified as Proxy Solicitation & Information Statements (PSI).
2020-03-09 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SR Biotech. It contains the agenda for the upcoming Annual General Meeting (AGM), including financial statement approval, board appointments, and proposed amendments to the articles of incorporation. This type of document is standard proxy material sent to shareholders to inform them of meeting details and solicit votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.